dc.contributor.author | Tsuzuki, S | |
dc.contributor.author | Enver, T | |
dc.date.accessioned | 2018-09-18T14:45:04Z | |
dc.date.issued | 2002-05-01 | |
dc.identifier | 9 | |
dc.identifier.citation | BLOOD, 2002, 99 pp. 3404 - 3410 | |
dc.identifier.issn | 0006-4971 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2803 | |
dc.identifier.doi | 10.1182/blood.V99.9.3404 | |
dc.description.abstract | Transcription factor GATA-2 Is Implicated in the survival and growth of multipotential progenitors. Here we report that the promyelocytic leukemia zinc finger (PLZF) protein can Interact with GATA-2 and can modify Its transactivation capacity. Fanconi anemia zinc finger (FAZF), a PLZF-homologous protein that has been variously described as ROG (repressor of GATA), and TZFP (testis zinc finger protein) also Interact with GATA-2. The zinc finger region of GATA-2 Is required for binding to PLZF and FAZF, but distinct Interfaces on the PLZF and FAZF molecules mediate the Interaction, suggesting that GATA-2 activity Is controlled by these 2 homologous proteins through distinct mechanisms. GATA-2 can also physically associate with the PLZF-RARalpha fusion protein generated by the t(11;17) chromosomal translocation associated with acute promyelocytic leukemia (APL). Functional experiments showed that this Interaction has the capacity to render GATA-dependent transcription responsive to treatment with ill combination of all-trans retinoic acid and the histone deacetylase Inhibitor trichostatin A (TSA). This combination of drugs has been shown to stimulate the terminal differentiation of leukemic t(11;17)-associated APL blasts, raising the possibility that GATA target genes may be Involved In the molecular pathogenesis of APL. (C) 2002 by The American Society of Hematology. | |
dc.format.extent | 3404 - 3410 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.title | Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1182/blood.V99.9.3404 | |
rioxxterms.licenseref.startdate | 2002-05-01 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | BLOOD | |
pubs.notes | unique-id: ISI:000175204300044 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR | |
pubs.volume | 99 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Enver, Tariq | en |